Bernie Sanders invites CEOs of J&J, Merck, Bristol Myers to testify on drug pricing

Senate Health Committee Chair Bernie Sanders (I-VT) and fellow Democrats on Tuesday announced that the CEOs of Johnson & Johnson, Merck and Bristol Myers Squibb have been asked to testify about why the US pays the highest prices in the world for prescription drugs. The senators will hold the hearing

US FTC challenges more than 100 patents as ‘improperly listed’ with FDA

The agency has sent letters to ten companies including AbbVie, AstraZeneca and GSK

Pharma companies aren't ‘future ready’ as pressure mounts from AI advances and IRA legislation, ...

Pharma is not ready for the future. Only 10% say they’re “future ready,” according to a recent survey of pharmaceutical leaders by Indegene. That’s a big decline from just two years ago when close to 60% told the commercial consulting group they felt well prepared for the future. What’s causing

Eisai launches digital dementia specialist company

Change of guard at drug price watchdog: ICER founder Steve Pearson to step down after 17 years

After growing the Institute for Clinical and Economic Review (ICER) into an influential drug pricing watchdog, Steve Pearson, M.D., is stepping down. | After growing the Institute for Clinical and Economic Review into an influential drug pricing watchdog, Steve Pearson is stepping down.